Novel regulators and molecular mechanisms of p53R2 and its disease relevance

E C Cho1, Y Yen2

  • 1Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan, ROC; Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei 110, Taiwan, ROC.

Biochimie
|January 23, 2016
PubMed

Insights

p53R2, a key enzyme in DNA repair and cell cycle control, plays a vital role in mitochondrial health and cancer. Its regulation and therapeutic potential are crucial for understanding and treating various diseases.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • p53R2 is a human ribonucleotide reductase subunit crucial for DNA repair, cell cycle arrest, and mitochondrial homeostasis.
  • Its regulation and involvement in disease progression, particularly cancer, are areas of active research.

Purpose of the Study:

  • To review the general background, novel regulatory findings, and medical prospects of p53R2.
  • To summarize the role of p53R2 in cellular mechanisms, disease relevance, and potential as a cancer therapeutic target.

Main Methods:

  • Literature review of molecular investigations and animal studies.
  • Analysis of research on p53R2 expression, regulation, and disease association.
  • Discussion of p53R2-mediated mechanisms in mitochondria, inflammation, and cancer.

Main Results:

  • p53R2 is involved in critical cellular functions including DNA repair and mitochondrial homeostasis.
  • Novel p53-independent regulatory mechanisms and transcription factors controlling p53R2 have been identified.
  • p53R2's role in mitochondrial diseases and cancer, along with its therapeutic potential, has been explored.

Conclusions:

  • p53R2 is a significant factor in cellular health and disease, especially cancer.
  • Understanding p53R2's complex regulation and functions offers new avenues for therapeutic intervention.
  • p53R2 represents a promising target for future cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K